David Spaventa

@JeffKerrPHL This lineup flat out stinks. Bad construction from top to bottom… pitching is not good either…

The #Phillies were 4-9 though 13 games in 2023 -- they won 90 games and made the NLCS. The Phillies were 5-8 through 13 games in 2022 -- they went to the World Series.

@AscendingBio @DrPatrick @ImmunityBio is this take accurate? $IBRX

$IBRX Learning Lessons from Other Companies $IBRX investors need to follow key events happening with other stocks. For example, $REPL was issued a CRL today. One of the issues prompting rejection was the "Inability to isolate the contribution of vusolimogene oderparepvec when administered in combination with nivolumab." Nivolumab is a checkpoint inhibitor. They state that the "study will not enable identification of the contribution of each component of the combination to the overall response rate.” For NSCLC, $IBRX has a phase 3 study that utilizes Anktiva, a checkpoint inhibitor, and Docetaxel (chemo). That is compared to Docetaxel alone. It is likely that the FDA will express concerns that this study design is problematic. That issue could have been addressed by giving the control group both Docetaxel and the checkpoint inhibitor. download.open.fda.gov/crl/CRL_BLA125…

@gainzalgo Crazy… every headline sends this one down …

$IBRX A billionaire in his 70s, still grinding every day to save lives and raise awareness for ALC and cancer. Taking on Big Pharma and even challenging the FDA. He’s personally responded to patients on Twitter who are desperate for help, which says everything. If there’s a modern-day hero, this is it. Not driven by money, but by purpose.

@TonyBrunoShow @DMRussini @MikeMiss25 @CrossingBroad lol! Another crazy lib arrested

The face you make when you slap @DMRussini out of the news cycle. @MikeMiss25 @CrossingBroad

@bullishbruk @VPrasadMDMPH @DrPatrick @DrMakaryFDA @LoriMills4CA42 Market up … $IBRX down… love the science hate the stock

$IBRX Just a theory: @VPrasadMDMPH is clearly anti-@DrPatrick and will likely block or undermine ANKTIVA while he’s at the helm. Maybe @DrMakaryFDA is holding off on approval until Prasad is gone to avoid the conflict? @LoriMills4CA42

@Concerned_Dad Fading again… should be 10 looks like 7.50 is heavy resistance now

$IBRX goes higher!!

@gainzalgo all the positive news and the stock can’t hold a bid

$IBRX so that controversial TV ad never actually aired… then how did the FDA even review it? Interesting question.

@JClarkNBCS Any glimmer of hope for this disaster of a club is over

Andrew Painter is at 90 pitches through four innings. He has given up four earned runs and nine hits.

@vulturetrades Guide

If you're an options trader - there's a hack you should learn that no one is talking about. It makes finding 100% trades way more consistent. I grew an account from $1k → $1,003,181 in 1 year using the exact same two concepts every single day. I made a FREE 5-page guide that will teach you this same exact strategy. Like + comment “Guide” and I will send you a DM. (Must be following to DM)

I spent 2 nights reading Claude trading codes. Then I built a trading bot that turned $1,400 into $238,000 in just 11 days. 67 trades. 80% win rate. Want to know how I did it? I’m handing out the trading bot guide for FREE Like and Repost and I will send it to you!

@ALulko Now selling off… I just don’t understand the price action here

$IBRX looking primed for a breakout! 🟢 Price action holding steady near $7.30–$7.50 with strong volume and bullish setup after the recent pullback — healthy base forming for the next leg up. Most recent news: Today (4/6/26), ImmunityBio addressed FDA correspondence on advertising and reaffirmed full commitment to compliance. Just weeks ago (3/31/26), they strengthened the balance sheet with $100M financing — including $75M non-dilutive — to fuel global ANKTIVA® expansion and the broader immunotherapy pipeline. Plus: NCCN guidelines update, Macau approval, sBLA on track, and massive revenue momentum. Bullish catalysts stacking up! Sources: ir.immunitybio.com/company/press-… businesswire.com/news/home/2026… #IBRX #ImmunityBio #Biotech NFA — DYOR 🚀

@Phillies @IBX Happy Easter… Taijuan sucks… leave him in Colorado

Easter Sunday Baseball #RingTheBell

@MikeMiss25 Mike has been waiting 18 months to send that

So…gas and groceries. How we feeling bout those now?

@norveclifinance Let’s see a 25% rip on Monday

Micron’s stacked GDDR could slash Samsung and SK hynix market share by 40-50% once it reaches the market. This is a serious disruption to the AI memory landscape. $MU

@JesseCohenInv No one is bidding it up over a long weekend

US stock futures stay lower despite the best payrolls report since 2024. What happened to the bulls?

@theblockspot Threat to what?

Paul George… dangerous. Tyrese Maxey… dangerous. VJ Edgecombe… dangerous. Joel Embiid… dangerous. Laugh if you want. The Sixers are a legitimate threat.

@TradexWhisperer $IBRX solving rare disease without the destruction of healthy cells

What's your single most bullish company right now, the one you'd buy regardless of war, and why? Let's collect some data from the crowd

@DeItaone Classic French prose here

Macron says it is unrealistic to open Hormuz Strait by force